​

Savara (SVRA) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

SVRA Stock Forecast

Savara (SVRA) stock forecast, based on 10 Wall Street analysts, predicts a 12-month average price target of $9.00, with a high of $11.00 and a low of $5.00. This represents a 104.08% increase from the last price of $4.41.

$3 $4 $5 $6 $7 $8 $9 $10 $11 High: $11 Avg: $9 Low: $5 Last Closed Price: $4.41

SVRA Stock Rating

Savara stock's rating consensus is Buy, based on 10 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 8 Buy (80.00%), 2 Hold (20.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 10 0 2 8 Strong Sell Sell Hold Buy Strong Buy

SVRA Price Target Upside V Benchmarks

TypeNameUpside
StockSavara104.08%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts133
Avg Price Target$11.00$9.00$9.00
Last Closing Price$4.41$4.41$4.41
Upside/Downside149.43%104.08%104.08%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 2534---7
Sep, 2534---7
Aug, 25242--8
Jul, 25242--8
Jun, 25242--8
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 23, 2025JMP Securities$11.00$4.24159.43%149.43%
Sep 09, 2025Guggenheim$11.00$3.82187.96%149.43%
Aug 15, 2025Andrew FeinH.C. Wainwright$5.00$3.0961.81%13.38%
Aug 13, 2024Jonathan WollebenJMP Securities$4.50$2.04120.59%2.04%
Jun 27, 2024Vamil DivanGuggenheim$5.00$1.92160.42%13.38%
Jun 27, 2024Andrew FeinH.C. Wainwright$5.00$1.92160.42%13.38%
Jun 27, 2024Jonathan WollebenJMP Securities$5.00$1.98152.53%13.38%
May 21, 2024Francois BriseboisOppenheimer$5.50$2.16154.63%24.72%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 23, 2025CitigroupOutperformOutperformhold
Sep 09, 2025GuggenheimBuyBuyhold
Sep 08, 2025OppenheimerOutperformOutperformhold
Sep 03, 2025H.C. WainwrightBuyBuyhold
Aug 15, 2025H.C. WainwrightNeutralBuyupgrade
May 29, 2025H.C. WainwrightBuyNeutraldowngrade
May 28, 2025GuggenheimBuyBuyhold
Oct 03, 2024Piper SandlerOverweightOverweighthold
Oct 01, 2024H.C. WainwrightBuyBuyhold
Aug 13, 2024JMP SecuritiesOutperformOutperformhold

Financial Forecast

EPS Forecast

Dec 20 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.86$-0.33$-0.48----
Avg Forecast$-0.62$-0.35$-0.46$-0.49$-0.25$-0.01$0.21
High Forecast$-0.62$-0.34$-0.45$-0.46$-0.04$0.18$0.21
Low Forecast$-0.62$-0.36$-0.47$-0.54$-0.44$-0.16$0.21
Surprise %38.71%-5.71%4.35%----

Revenue Forecast

$0 $40M $80M $120M $160M $200M Dec 20 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$257.00K------
Avg Forecast$267.25K--$1.39M$50.60M$119.56M$185.09M
High Forecast$267.25K--$1.39M$50.60M$122.02M$185.09M
Low Forecast$267.25K--$1.39M$50.60M$117.11M$185.09M
Surprise %-3.84%------

Net Income Forecast

$-150M $-110M $-70M $-30M $10M $50M Dec 20 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-51.10M$-54.70M$-95.88M----
Avg Forecast$-102.70M$-58.10M$-76.20M$-83.07M$-58.35M$-1.07M$35.11M
High Forecast$-102.70M$-56.44M$-74.51M$-76.68M$-6.61M$29.94M$35.11M
Low Forecast$-102.70M$-59.76M$-77.89M$-89.46M$-72.69M$-25.81M$35.11M
Surprise %-50.25%-5.85%25.83%----

SVRA Forecast FAQ

Is Savara stock a buy?

Savara stock has a consensus rating of Buy, based on 10 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 8 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Savara is a favorable investment for most analysts.

What is Savara's price target?

Savara's price target, set by 10 Wall Street analysts, averages $9 over the next 12 months. The price target range spans from $5 at the low end to $11 at the high end, suggesting a potential 104.08% change from the previous closing price of $4.41.

How does Savara stock forecast compare to its benchmarks?

Savara's stock forecast shows a 104.08% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Savara over the past three months?

  • October 2025: 42.86% Strong Buy, 57.14% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • September 2025: 42.86% Strong Buy, 57.14% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 25.00% Strong Buy, 50.00% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.

What is Savara’s EPS forecast?

Savara's average annual EPS forecast for its fiscal year ending in December 2025 is $-0.49, marking a 2.08% increase from the reported $-0.48 in 2024. Estimates for the following years are $-0.25 in 2026, $-0.01 in 2027, and $0.21 in 2028.

What is Savara’s revenue forecast?

Savara's average annual revenue forecast for its fiscal year ending in December 2025 is $1.39M, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $50.6M, followed by $119.56M for 2027, and $185.09M for 2028.

What is Savara’s net income forecast?

Savara's net income forecast for the fiscal year ending in December 2025 stands at $-83.07M, representing a -13.36% decrease from the reported $-95.881M in 2024. Projections indicate $-58.347M in 2026, $-1.071M in 2027, and $35.11M in 2028.